| 1 | Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer | 1.2 | 2 | Citations (PDF) |
| 2 | The WASP/WAVE Protein Family in Breast Cancer and Their Role in the Metastatic Cascade | 1.2 | 3 | Citations (PDF) |
| 3 | Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy | 3.2 | 4 | Citations (PDF) |
| 4 | Noggin Promotes Cell Proliferation Through Up-regulating EGFR/HER2 in Pancreatic Cancer Cells | 1.2 | 0 | Citations (PDF) |
| 5 | CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms | 1.2 | 0 | Citations (PDF) |
| 6 | Association study of hypertension susceptibility genes
ITGA9, MOV10
, and
CACNB2
with preeclampsia in Chinese Han population | 1.0 | 4 | Citations (PDF) |
| 7 | Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort Study | 2.5 | 5 | Citations (PDF) |
| 8 | Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review) | 2.7 | 14 | Citations (PDF) |
| 9 | Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance | 1.2 | 0 | Citations (PDF) |
| 10 | Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms | 1.7 | 7 | Citations (PDF) |
| 11 | Analysis of androgen receptor expression and activity in the mouse brain | 2.7 | 21 | Citations (PDF) |
| 12 | Upregulated bone morphogenetic protein 8A (BMP8A) in triple negative breast cancer (TNBC) and its involvement in the bone metastasis | 2.8 | 4 | Citations (PDF) |
| 13 | Oestrogen Represses Noggin Expression by Interfering With BMP/Smad Signalling in ER Positive Breast Cancer | 0.8 | 3 | Citations (PDF) |
| 14 | Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer | 2.7 | 4 | Citations (PDF) |
| 15 | Putative Dual Roles of Bone Morphogenetic Protein 8B (BMP8B) in Disease Progression of Gastric Cancer | 0.5 | 0 | Citations (PDF) |
| 16 | Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway | 1.9 | 4 | Citations (PDF) |
| 17 | Molecular mechanism of bone metastasis in breast cancer | 1.7 | 15 | Citations (PDF) |
| 18 | EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer | 2.7 | 2 | Citations (PDF) |
| 19 | Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance | 3.6 | 12 | Citations (PDF) |
| 20 | Osteopontin and Cancer: Insights into Its Role in Drug Resistance | 2.5 | 32 | Citations (PDF) |
| 21 | Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers | 3.2 | 14 | Citations (PDF) |
| 22 | Transglutaminase-4 (Prostate Transglutaminase), a Potential Biological Factor and Clinical Indicator for the Diagnosis and Prognosis of Prostate Cancer | 0.8 | 4 | Citations (PDF) |
| 23 | nWASP Inhibition Increases Wound Healing via TrKb/PLCγ Signalling | 3.1 | 0 | Citations (PDF) |
| 24 | ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies | 0.8 | 5 | Citations (PDF) |
| 25 | Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients’ Treatment Responses | 0.8 | 3 | Citations (PDF) |
| 26 | Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer | 1.7 | 13 | Citations (PDF) |
| 27 | Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells | 3.2 | 7 | Citations (PDF) |
| 28 | Claudin-10 in the Blood Brain Barrier Function of Cerebral Endothelial Cells and Transendothelial Invasion of Breast Cancer Cells | 0.8 | 7 | Citations (PDF) |
| 29 | Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment | 2.1 | 8 | Citations (PDF) |
| 30 | Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance | 2.5 | 12 | Citations (PDF) |
| 31 | Kinase D-interacting Substrate of 220 kDa Is Overexpressed in Gastric Cancer and Associated With Local Invasion | 1.2 | 0 | Citations (PDF) |
| 32 | Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy | 4.4 | 23 | Citations (PDF) |
| 33 | Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy | 2.3 | 14 | Citations (PDF) |
| 34 | Timely identification and successful treatment of acute fatty liver of pregnancy without obvious clinical symptoms | 1.0 | 4 | Citations (PDF) |
| 35 | Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells | 1.7 | 30 | Citations (PDF) |
| 36 | Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro | 1.8 | 9 | Citations (PDF) |
| 37 | Hepatitis A Virus Cellular Receptor 1 (HAVcr-1) Initiates Prostate Cancer Progression in Human Cells via Hepatocyte Growth Factor (HGF)-Induced Changes in Junctional Integrity | 3.1 | 1 | Citations (PDF) |
| 38 | Genetic susceptibility analysis of FGF5 polymorphism to preeclampsia in Chinese Han population | 1.1 | 15 | Citations (PDF) |
| 39 | Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone | 2.7 | 14 | Citations (PDF) |
| 40 | Sex Hormone-regulatedCMG2Is Involved in Breast and Prostate Cancer Progression | 1.2 | 5 | Citations (PDF) |
| 41 | EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance | 3.2 | 9 | Citations (PDF) |
| 42 | Protective effect of baicalin against pulmonary arterial hypertension vascular remodeling through regulation of TNF‐α signaling pathway | 1.5 | 33 | Citations (PDF) |
| 43 | Lead DEAD/H box helicase biomarkers with the therapeutic potential identified by integrated bioinformatic approaches in lung cancer | 2.7 | 16 | Citations (PDF) |
| 44 | NUPR1 and its potential role in cancer and pathological conditions (Review) | 3.6 | 58 | Citations (PDF) |
| 45 | SIPA1 Is a Modulator of HGF/MET Induced Tumour Metastasis via the Regulation of Tight Junction-Based Cell to Cell Barrier Function | 2.7 | 7 | Citations (PDF) |
| 46 | Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model | 2.2 | 8 | Citations (PDF) |
| 47 | EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance | 3.1 | 15 | Citations (PDF) |
| 48 | The G4 Resolvase DHX36 Possesses a Prognosis Significance and Exerts Tumour Suppressing Function Through Multiple Causal Regulations in Non-Small Cell Lung Cancer | 1.7 | 13 | Citations (PDF) |
| 49 | Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer | 3.8 | 24 | Citations (PDF) |
| 50 | Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer | 0.8 | 9 | Citations (PDF) |
| 51 | Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression | 3.6 | 5 | Citations (PDF) |
| 52 | Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers | 3.1 | 22 | Citations (PDF) |
| 53 | O1 Elevated expression level of capillary morphogenesis gene 2 in pancreatic ductal adenocarcinoma cell is associated with distant metastasis and poor prognosis | 0.4 | 0 | Citations (PDF) |
| 54 | O30 Aberrant expression of noggin has a subtype specific association with survival of breast cancer patients | 0.4 | 0 | Citations (PDF) |
| 55 | Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer | 3.3 | 12 | Citations (PDF) |
| 56 | Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging | 1.7 | 3 | Citations (PDF) |
| 57 | Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents | 1.6 | 25 | Citations (PDF) |
| 58 | PDCD4 Negatively Regulated Osteogenic Differentiation and Bone Defect Repair of Mesenchymal Stem Cells Through GSK-3β/β-Catenin Pathway | 1.3 | 11 | Citations (PDF) |
| 59 | Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer Progression | 3.1 | 7 | Citations (PDF) |
| 60 | Location, function and role of stromal cell‑derived factors and possible implications in cancer (Review) | 3.8 | 9 | Citations (PDF) |
| 61 | The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers | 2.7 | 26 | Citations (PDF) |
| 62 | Truncating Variants in
OBSCN
Gene Associated With Disease-Onset and Outcomes of Hypertrophic Cardiomyopathy | 1.9 | 16 | Citations (PDF) |
| 63 | Influence of anaesthetics on the production of cancer cell motogens, stromal cell‑derived factor‑1 and hepatocyte growth factor by fibroblasts | 1.1 | 2 | Citations (PDF) |
| 64 | Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone | 2.7 | 31 | Citations (PDF) |
| 65 | Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation | 2.2 | 8 | Citations (PDF) |
| 66 | Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer | 1.2 | 26 | Citations (PDF) |
| 67 | The protective effects of MSC‐EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway | 2.4 | 38 | Citations (PDF) |
| 68 | IL‐27 Rα+ cells promoted allorejection via enhancing STAT1/3/5 phosphorylation | 2.4 | 8 | Citations (PDF) |
| 69 | Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer | 1.7 | 35 | Citations (PDF) |
| 70 | Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways | 5.4 | 51 | Citations (PDF) |
| 71 | Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling | 2.8 | 64 | Citations (PDF) |
| 72 | Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers | 2.1 | 3 | Citations (PDF) |
| 73 | PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis | 1.7 | 84 | Citations (PDF) |
| 74 | TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer | 6.6 | 74 | Citations (PDF) |
| 75 | Stratification Using hTERT and Stem Cell Markers Confers a Good Prognosis in Invasive Breast Cancer | 1.2 | 2 | Citations (PDF) |
| 76 | IL-27Rα: A Novel Molecular Imaging Marker for Allograft Rejection | 3.2 | 5 | Citations (PDF) |
| 77 | STAT1 transcriptionally regulates the expression of S1PR1 by binding its promoter region | 1.6 | 21 | Citations (PDF) |
| 78 | Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer | 2.7 | 28 | Citations (PDF) |
| 79 | EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness | 1.7 | 16 | Citations (PDF) |
| 80 | Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells | 2.1 | 40 | Citations (PDF) |
| 81 | Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR | 3.6 | 16 | Citations (PDF) |
| 82 | The role of SIPA1 in the development of cancer and metastases (Review) | 0.9 | 3 | Citations (PDF) |
| 83 | Activity and mechanism of flavokawain A in inhibiting permeability‑glycoprotein expression in paclitaxel resistance of lung cancer | 1.1 | 16 | Citations (PDF) |
| 84 | DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways | 3.6 | 10 | Citations (PDF) |
| 85 | A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma | 3.8 | 28 | Citations (PDF) |
| 86 | Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer | 2.5 | 25 | Citations (PDF) |
| 87 | MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and Growth | 0.8 | 16 | Citations (PDF) |
| 88 | Overexpression of Certain Cancer Stem Cell Marker Confer A Good Prognosis In Invasive Breast Cancer | 0.9 | 0 | Citations (PDF) |
| 89 | Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma | 1.8 | 15 | Citations (PDF) |
| 90 | Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma | 3.6 | 8 | Citations (PDF) |
| 91 | Development and validation of a gene expression test to identify hard-to-heal chronic venous leg ulcers | 0.4 | 16 | Citations (PDF) |
| 92 | METTL3 promotes the proliferation and mobility of gastric cancer cells | 0.8 | 120 | Citations (PDF) |
| 93 | Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis | 1.2 | 34 | Citations (PDF) |
| 94 | Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer | 6.5 | 60 | Citations (PDF) |
| 95 | Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer | 1.2 | 10 | Citations (PDF) |
| 96 | Jinmaitong, a Traditional Chinese Compound Prescription, Ameliorates the Streptozocin-Induced Diabetic Peripheral Neuropathy Rats by Increasing Sciatic Nerve IGF-1 and IGF-1R Expression | 2.6 | 33 | Citations (PDF) |
| 97 | TLR5: A prognostic and monitoring indicator for triple-negative breast cancer | 6.6 | 32 | Citations (PDF) |
| 98 | OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase | 2.7 | 17 | Citations (PDF) |
| 99 | HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer | 0.8 | 9 | Citations (PDF) |
| 100 | Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells | 3.8 | 24 | Citations (PDF) |
| 101 | Baicalin attenuates myocardial ischemia‐reperfusion injury through Akt/NF‐κB pathway | 1.8 | 59 | Citations (PDF) |
| 102 | Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways | 3.8 | 38 | Citations (PDF) |
| 103 | SRPK1‑siRNA suppresses K562 cell growth and induces apoptosis via the PARP‑caspase3 pathway | 2.3 | 17 | Citations (PDF) |
| 104 | Suppression of the NF‑κB signaling pathway in colon cancer cells by the natural compound Riccardin D from Dumortierahirsute | 2.3 | 19 | Citations (PDF) |
| 105 | [Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells | 3.6 | 0 | Citations (PDF) |
| 106 | Pretreatment with Total Flavonoid Extract from Dracocephalum Moldavica L. Attenuates Ischemia Reperfusion-induced Apoptosis | 2.7 | 42 | Citations (PDF) |
| 107 | Effects of Lidocaine and Ropivacaine on Gastric Cancer Cells Through Down-regulation of ERK1/2 Phosphorylation In Vitro | 0.8 | 27 | Citations (PDF) |
| 108 | Usefulness of conventional magnetic resonance imaging, diffusion tensor imaging and neurite orientation dispersion and density imaging in evaluating postoperative function in patients with cervical spondylotic myelopathy | 4.0 | 19 | Citations (PDF) |
| 109 | mRNA Expression of CDK2AP1 in Human Breast Cancer: Correlation with Clinical and Pathological Parameters | 1.2 | 10 | Citations (PDF) |
| 110 | Ginsenoside Rb1 administration attenuates focal cerebral ischemic reperfusion injury through inhibition of HMGB1 and inflammation signals | 1.2 | 24 | Citations (PDF) |
| 111 | Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia | 2.4 | 13 | Citations (PDF) |
| 112 | [Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase�1 promotes cancer cells migration in gastric cancer: Clinical implications | 2.2 | 10 | Citations (PDF) |
| 113 | Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer | 3.6 | 11 | Citations (PDF) |
| 114 | Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer | 3.6 | 5 | Citations (PDF) |
| 115 | Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer | 6.2 | 53 | Citations (PDF) |
| 116 | Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis | 2.8 | 21 | Citations (PDF) |
| 117 | The discovery of purine-based agents targeting triple-negative breast cancer and the αB-crystallin/VEGF protein–protein interaction | 2.2 | 7 | Citations (PDF) |
| 118 | PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells | 2.3 | 20 | Citations (PDF) |
| 119 | Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression | 3.6 | 16 | Citations (PDF) |
| 120 | The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer | 2.2 | 13 | Citations (PDF) |
| 121 | Human osteopontin: Potential clinical applications in cancer (Review) | 3.8 | 85 | Citations (PDF) |
| 122 | Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds | 1.2 | 23 | Citations (PDF) |
| 123 | Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells | 1.5 | 25 | Citations (PDF) |
| 124 | MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells | 4.1 | 49 | Citations (PDF) |
| 125 | Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors | 3.6 | 6 | Citations (PDF) |
| 126 | Kidins220 and tumour development: Insights into a complexity of cross-talk among signalling pathways (Review) | 3.8 | 9 | Citations (PDF) |
| 127 | MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma | 2.7 | 77 | Citations (PDF) |
| 128 | In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing | 2.7 | 8 | Citations (PDF) |
| 129 | PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation | 5.2 | 39 | Citations (PDF) |
| 130 | Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion | 2.1 | 19 | Citations (PDF) |
| 131 | Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells | 2.3 | 82 | Citations (PDF) |
| 132 | Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development | 3.3 | 19 | Citations (PDF) |
| 133 | Expression of phospholipase C isozymes in human breast cancer and their clinical significance | 2.2 | 33 | Citations (PDF) |
| 134 | Aspects of Carbon Monoxide in Form of CO‐Releasing Molecules Used in Cancer Treatment: More Light on the Way | 2.7 | 71 | Citations (PDF) |
| 135 | ShenLingLan Influences the Attachment and Migration of Ovarian Cancer Cells Potentially through the GSK3 Pathway | 0.9 | 5 | Citations (PDF) |
| 136 | MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer | 3.0 | 59 | Citations (PDF) |
| 137 | KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer | 1.5 | 71 | Citations (PDF) |
| 138 | A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression | 0.8 | 11 | Citations (PDF) |
| 139 | Prostate Transglutaminase (TGase-4) Induces Epithelial– to-Mesenchymal Transition in Prostate Cancer Cells | 0.8 | 14 | Citations (PDF) |
| 140 | OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells In Vitro | 0.8 | 16 | Citations (PDF) |
| 141 | Clinical Significance of PD1 and PDL1 in Human Breast Cancer | 0.8 | 29 | Citations (PDF) |
| 142 | Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer | 0.8 | 37 | Citations (PDF) |
| 143 | High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics | 0.8 | 12 | Citations (PDF) |
| 144 | HIF1α-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment | 0.8 | 81 | Citations (PDF) |
| 145 | The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways | 0.8 | 24 | Citations (PDF) |
| 146 | Comparison of Different Muscle-Relaxant Anesthetics on Growth, Migration and Invasion of Gastric Cancer Cells | 0.8 | 10 | Citations (PDF) |
| 147 | Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma | 0.8 | 5 | Citations (PDF) |
| 148 | Knockdown of EPHA1 Using CRISPR/CAS9 Suppresses Aggressive Properties of Ovarian Cancer Cells | 0.8 | 19 | Citations (PDF) |
| 149 | Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival | 1.2 | 21 | Citations (PDF) |
| 150 | Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells | 0.8 | 4 | Citations (PDF) |
| 151 | Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma | 0.8 | 8 | Citations (PDF) |
| 152 | NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial–Mesenchymal Transition | 0.8 | 5 | Citations (PDF) |
| 153 | Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion | 0.8 | 8 | Citations (PDF) |
| 154 | Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model | 0.8 | 2 | Citations (PDF) |
| 155 | Clinical Correlation Between WISP2 and β-Catenin in Gastric Cancer | 0.8 | 5 | Citations (PDF) |
| 156 | Reduced Expression of RanBPM Is Associated with Poorer Survival from Lung Cancer and Increased Proliferation and Invasion of Lung Cancer Cells In Vitro | 0.8 | 6 | Citations (PDF) |
| 157 | Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment | 0.8 | 4 | Citations (PDF) |
| 158 | Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population | 0.8 | 1 | Citations (PDF) |
| 159 | Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial–Mesenchymal Transition in Renal Cell Carcinoma In Vivo | 0.8 | 1 | Citations (PDF) |
| 160 | Application of Localization and Needle Placement Guided by Mammographic, Ultrasound and Fiberoptic Ductoscopy for Resection of Non-palpable Breast Lesions | 0.8 | 5 | Citations (PDF) |
| 161 | Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer | 0.8 | 10 | Citations (PDF) |
| 162 | Tumour endothelial marker-8 in wound healing and its impact on the proliferation and migration of keratinocytes | 3.8 | 4 | Citations (PDF) |
| 163 | Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer | 3.6 | 20 | Citations (PDF) |
| 164 | Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review) | 2.2 | 19 | Citations (PDF) |
| 165 | The role of JAM-B in cancer and cancer metastasis (Review) | 2.2 | 22 | Citations (PDF) |
| 166 | Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression | 2.2 | 8 | Citations (PDF) |
| 167 | Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells | 3.6 | 15 | Citations (PDF) |
| 168 | The splice variant Ehm2/1 in breast cancer MCF-7 cells interacted with β-catenin and increased its localization to plasma membrane | 4.0 | 2 | Citations (PDF) |
| 169 | The clinical significance and impact of interleukin 15 on keratinocyte cell growth and migration | 3.8 | 21 | Citations (PDF) |
| 170 | Expression of the SOCS family in human chronic wound tissues: Potential implications for SOCS in chronic wound healing | 3.8 | 18 | Citations (PDF) |
| 171 | Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer | 1.5 | 34 | Citations (PDF) |
| 172 | Potential implications of interleukin-7 in chronic wound healing | 1.2 | 23 | Citations (PDF) |
| 173 | Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer | 3.6 | 26 | Citations (PDF) |
| 174 | The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway | 3.2 | 57 | Citations (PDF) |
| 175 | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis | 3.5 | 23 | Citations (PDF) |
| 176 | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro | 3.6 | 7 | Citations (PDF) |
| 177 | Potential Roles of Suppressor of Cytokine Signaling in Wound Healing | 1.3 | 33 | Citations (PDF) |
| 178 | Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies | 6.5 | 45 | Citations (PDF) |
| 179 | Clinical and Therapeutic Implications of Follistatin in Solid Tumours | 1.2 | 41 | Citations (PDF) |
| 180 | Unveiling the potential of prohibitin in cancer | 6.5 | 61 | Citations (PDF) |
| 181 | The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients | 2.1 | 17 | Citations (PDF) |
| 182 | Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells | 3.8 | 11 | Citations (PDF) |
| 183 | YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells | 4.8 | 12 | Citations (PDF) |
| 184 | Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis | 2.1 | 38 | Citations (PDF) |
| 185 | Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes | 2.5 | 5 | Citations (PDF) |
| 186 | WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways | 4.1 | 30 | Citations (PDF) |
| 187 | Designing a novel high-throughput AlphaLISA assay to quantify plasma NHERF1 as a non-small cell lung cancer biomarker | 4.0 | 3 | Citations (PDF) |
| 188 | Reduced expression of semaphorin 4D and plexin-B in breast cancer is associated with poorer prognosis and the potential linkage with oestrogen receptor | 2.2 | 27 | Citations (PDF) |
| 189 | Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications | 2.2 | 20 | Citations (PDF) |
| 190 | Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review) | 3.8 | 119 | Citations (PDF) |
| 191 | Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis | 3.6 | 13 | Citations (PDF) |
| 192 | Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells | 2.2 | 20 | Citations (PDF) |
| 193 | Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells | 2.2 | 14 | Citations (PDF) |
| 194 | Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis | 1.1 | 154 | Citations (PDF) |
| 195 | Ephrin-Bs Drive Junctional Downregulation and Actin Stress Fiber Disassembly to Enable Wound Re-epithelialization | 4.4 | 83 | Citations (PDF) |
| 196 | The role of death-associated protein 3 in apoptosis, anoikis and human cancer | 3.8 | 31 | Citations (PDF) |
| 197 | Tissue invasion and metastasis: Molecular, biological and clinical perspectives | 10.5 | 473 | Citations (PDF) |
| 198 | EPLIN: a fundamental actin regulator in cancer metastasis? | 6.8 | 48 | Citations (PDF) |
| 199 | Designing a broad-spectrum integrative approach for cancer prevention and treatment | 10.5 | 271 | Citations (PDF) |
| 200 | The Clinical and Therapeutic Uses of MDM2 and PSMA and Their Potential Interaction in Aggressive Cancers | 1.0 | 5 | Citations (PDF) |
| 201 | Targeting Multiple Signaling Pathways, a Potential Explanation to the Therapeutic Actions of Traditional Chinese Medicine in Cancer? | 1.2 | 0 | Citations (PDF) |
| 202 | Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis | 3.6 | 9 | Citations (PDF) |
| 203 | Impact of fibroblast activation protein on osteosarcoma cell lines in vitro | 1.1 | 21 | Citations (PDF) |
| 204 | Capillary morphogenesis gene 2 regulates adhesion and invasiveness of prostate cancer cells | 1.1 | 9 | Citations (PDF) |
| 205 | KIAA1199 and its biological role in human cancer and cancer cells (Review) | 2.2 | 55 | Citations (PDF) |
| 206 | Wnt1 inducible signalling pathway protein-2 (WISP-2/CCN5): Roles and regulation in human cancers (Review) | 2.2 | 29 | Citations (PDF) |
| 207 | Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer | 2.1 | 36 | Citations (PDF) |
| 208 | FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway | 3.6 | 78 | Citations (PDF) |
| 209 | Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis | 1.8 | 13 | Citations (PDF) |
| 210 | Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo | 1.8 | 36 | Citations (PDF) |
| 211 | Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development | 4.0 | 150 | Citations (PDF) |
| 212 | Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer | 2.5 | 69 | Citations (PDF) |
| 213 | Tumour angiogenesis and repulsive guidance molecule b: A role in HGF- and BMP-7-mediated angiogenesis | 3.6 | 16 | Citations (PDF) |
| 214 | HGF and the regulation of tight junctions in human prostate cancer cells | 2.2 | 15 | Citations (PDF) |
| 215 | Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death | 2.2 | 19 | Citations (PDF) |
| 216 | Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma | 2.2 | 48 | Citations (PDF) |
| 217 | The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (Review) | 2.3 | 149 | Citations (PDF) |
| 218 | FERM family proteins and their importance in cellular movements and wound healing (Review) | 3.8 | 46 | Citations (PDF) |
| 219 | Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes | 5.2 | 409 | Citations (PDF) |
| 220 | Evidence for Tumour Suppressor Function of DOK7 in Human Breast Cancer | 0.2 | 5 | Citations (PDF) |
| 221 | Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer | 1.8 | 49 | Citations (PDF) |
| 222 | Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development | 6.5 | 28 | Citations (PDF) |
| 223 | Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer | 2.5 | 109 | Citations (PDF) |
| 224 | The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer | 6.8 | 108 | Citations (PDF) |
| 225 | Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain | 4.8 | 16 | Citations (PDF) |
| 226 | Molecular angiogenic events of a two‐herb wound healing formula involving MAPK and Akt signaling pathways in human vascular endothelial cells | 2.0 | 17 | Citations (PDF) |
| 227 | Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells | 0.8 | 26 | Citations (PDF) |
| 228 | Expressed in high metastatic cells (Ehm2) is a positive regulator of keratinocyte adhesion and motility: The implication for wound healing | 1.8 | 12 | Citations (PDF) |
| 229 | Breast cancer‐derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet‐derived growth factor receptor signaling | 1.8 | 15 | Citations (PDF) |
| 230 | Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer | 2.2 | 34 | Citations (PDF) |
| 231 | Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro | 2.2 | 13 | Citations (PDF) |
| 232 | The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I‐mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly | 2.3 | 97 | Citations (PDF) |
| 233 | Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells | 1.2 | 35 | Citations (PDF) |
| 234 | Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells | 3.6 | 4 | Citations (PDF) |
| 235 | The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review) | 3.8 | 62 | Citations (PDF) |
| 236 | Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor | 3.6 | 6 | Citations (PDF) |
| 237 | Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway | 3.6 | 21 | Citations (PDF) |
| 238 | Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: The pivotal role of focal adhesion kinase signalling | 2.2 | 15 | Citations (PDF) |
| 239 | Potential implication of IL-24 in lymphangiogenesis of human breast cancer | 3.8 | 12 | Citations (PDF) |
| 240 | The Expression of the Nectin Complex in Human Breast Cancer and the Role of Nectin-3 in the Control of Tight Junctions during Metastasis | 1.5 | 37 | Citations (PDF) |
| 241 | Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy | 4.1 | 31 | Citations (PDF) |
| 242 | Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I) | 1.4 | 10 | Citations (PDF) |
| 243 | Role of HuR in keratinocyte migration and wound healing | 2.3 | 5 | Citations (PDF) |
| 244 | Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells | 3.6 | 18 | Citations (PDF) |
| 245 | Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells | 3.8 | 5 | Citations (PDF) |
| 246 | UDP-Glucuronosyltransferase (UGT) 1A9-Overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between Breast Cancer Resistance Protein (BRCP) and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP | 2.0 | 39 | Citations (PDF) |
| 247 | Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression | 2.7 | 7 | Citations (PDF) |
| 248 | The influence of matriptase-2 on prostate cancer in vitro: A possible role for β-catenin | 2.2 | 13 | Citations (PDF) |
| 249 | Biological influence of brain-derived neurotrophic factor on breast cancer cells | 3.6 | 33 | Citations (PDF) |
| 250 | Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway | 3.6 | 16 | Citations (PDF) |
| 251 | Μolecular impact of bone morphogenetic protein�7, on lung cancer cells and its clinical significance | 3.8 | 17 | Citations (PDF) |
| 252 | Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer | 1.8 | 0 | Citations (PDF) |
| 253 | Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo | 2.4 | 9 | Citations (PDF) |
| 254 | 19. Does MDA-7/IL-24 have an effect on the process of lymphangiogenesis? | 0.9 | 0 | Citations (PDF) |
| 255 | Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways | 4.0 | 84 | Citations (PDF) |
| 256 | The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions | 2.1 | 17 | Citations (PDF) |
| 257 | Expression of IL‐24 and IL‐24 receptors in human wound tissues and the biological implications of IL‐24 on keratinocytes | 2.0 | 28 | Citations (PDF) |
| 258 | Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways | 7.6 | 61 | Citations (PDF) |
| 259 | Protein Tyrosine Phosphatase µ (PTP µ or PTPRM), a Negative Regulator of Proliferation and Invasion of Breast Cancer Cells, Is Associated with Disease Prognosis | 1.5 | 48 | Citations (PDF) |
| 260 | Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications | 1.2 | 134 | Citations (PDF) |
| 261 | Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling | 1.8 | 38 | Citations (PDF) |
| 262 | CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer | 5.2 | 106 | Citations (PDF) |
| 263 | Expression Profile of Epithelial Protein Lost in Neoplasm-Alpha (EPLIN-α) in Human Pulmonary Cancer and Its Impact on SKMES-1 Cells <i>in vitro</i> | 0.2 | 7 | Citations (PDF) |
| 264 | Tight junctions in cancer metastasis | 5.8 | 102 | Citations (PDF) |
| 265 | The Claudin family and its role in cancer and metastasis | 5.8 | 98 | Citations (PDF) |
| 266 | EPLIN is a Negative Regulator of Prostate Cancer Growth and Invasion | 3.1 | 31 | Citations (PDF) |
| 267 | Cancer metastasis challenges progress and the opportunities | 2.6 | 8 | Citations (PDF) |
| 268 | The Role of Transglutaminases in the Pathophysiology of Prostate Cancer | 2.0 | 1 | Citations (PDF) |
| 269 | The FERM family proteins in cancer invasion and metastasis | 5.8 | 31 | Citations (PDF) |
| 270 | Type II Transmembrane Serine Protease (TTSP) deregulation in cancer | 5.8 | 62 | Citations (PDF) |
| 271 | Bone morphogenetic protein and bone metastasis, implication and therapeutic potential | 5.8 | 50 | Citations (PDF) |
| 272 | Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells | 1.2 | 13 | Citations (PDF) |
| 273 | Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability | 1.5 | 35 | Citations (PDF) |
| 274 | Pattern of expression of CCN family members Cyr61, CTGF and NOV in human acute and chronic wounds | 1.2 | 8 | Citations (PDF) |
| 275 | Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9 | 2.2 | 25 | Citations (PDF) |
| 276 | Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration | 2.2 | 17 | Citations (PDF) |
| 277 | Wnt5a as an Effector of TGFβ in Mammary Development and Cancer | 1.6 | 47 | Citations (PDF) |
| 278 | Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer | 3.8 | 56 | Citations (PDF) |
| 279 | Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer | 4.8 | 14 | Citations (PDF) |
| 280 | The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance | 4.8 | 33 | Citations (PDF) |
| 281 | Prostate Transglutaminase: A Unique Transglutaminase and Its Role in Prostate Cancer | 1.0 | 21 | Citations (PDF) |
| 282 | Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer | 1.2 | 23 | Citations (PDF) |
| 283 | Claudin-11 decreases the invasiveness of bladder cancer cells | 2.2 | 25 | Citations (PDF) |
| 284 | Misexpression of Wingless-Related MMTV Integration Site 5A in Mouse Mammary Gland Inhibits the Milk Ejection Response and Regulates Connexin43 Phosphorylation1 | 1.8 | 14 | Citations (PDF) |
| 285 | αB-Crystallin, an Effector of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells | 2.0 | 61 | Citations (PDF) |
| 286 | Claudin-5 participates in the regulation of endothelial cell motility | 2.4 | 29 | Citations (PDF) |
| 287 | Lymphangiogenesis and cancer metastasis | 5.8 | 35 | Citations (PDF) |
| 288 | Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer | 1.2 | 11 | Citations (PDF) |
| 289 | Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications | 3.6 | 55 | Citations (PDF) |
| 290 | Loss of occludin leads to the progression of human breast cancer | 3.8 | 100 | Citations (PDF) |
| 291 | The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis | 5.8 | 38 | Citations (PDF) |
| 292 | Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer | 2.1 | 98 | Citations (PDF) |
| 293 | iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway | 2.1 | 62 | Citations (PDF) |
| 294 | GDF‐9 promotes the growth of prostate cancer cells by protecting them from apoptosis | 2.5 | 7 | Citations (PDF) |
| 295 | Tumour suppressor function of MDA-7/IL-24 in human breast cancer | 3.8 | 46 | Citations (PDF) |
| 296 | Expression of WAVEs, the WASP (Wiskott-Aldrich syndrome protein) family of verprolin homologous proteins in human wound tissues and the biological influence on human keratinocytes | 2.0 | 14 | Citations (PDF) |
| 297 | Bone morphogenetic protein‐10 (BMP‐10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer | 2.9 | 44 | Citations (PDF) |
| 298 | Clinical Implications of the Influence of Ehm2 on the Aggressiveness of Breast Cancer Cells through Regulation of Matrix Metalloproteinase-9 Expression | 2.0 | 19 | Citations (PDF) |
| 299 | Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway | 2.2 | 12 | Citations (PDF) |
| 300 | The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells | 3.6 | 22 | Citations (PDF) |
| 301 | WAVE3 is associated with invasiveness in prostate cancer cells | 0.8 | 40 | Citations (PDF) |
| 302 | Growth and differentiation factor 9 (GDF-9) induces epithelial–mesenchymal transition in prostate cancer cells | 2.4 | 19 | Citations (PDF) |
| 303 | High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer | 1.7 | 35 | Citations (PDF) |
| 304 | Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review) | 3.8 | 50 | Citations (PDF) |
| 305 | Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid | 3.2 | 24 | Citations (PDF) |
| 306 | Vascular endothelial growth inhibitor in human cancer (Review) | 3.8 | 29 | Citations (PDF) |
| 307 | The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters | 2.1 | 103 | Citations (PDF) |
| 308 | The mRNA expression of SATB1 and SATB2 in human breast cancer | 3.8 | 90 | Citations (PDF) |
| 309 | Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer | 2.8 | 103 | Citations (PDF) |
| 310 | Loss of tight junction barrier function and its role in cancer metastasis | 1.5 | 442 | Citations (PDF) |
| 311 | The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway | 1.8 | 37 | Citations (PDF) |
| 312 | Bone Morphogenetic Protein-10 Suppresses the Growth and Aggressiveness of Prostate Cancer Cells Through a Smad Independent Pathway | 3.1 | 50 | Citations (PDF) |
| 313 | Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro | 3.6 | 6 | Citations (PDF) |
| 314 | The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance | 3.6 | 15 | Citations (PDF) |
| 315 | Transcript analyses of stromal cell derived factors (SDFs): SDF-2, SDF-4 and SDF-5 reveal a different pattern of expression and prognostic association in human breast cancer | 3.6 | 14 | Citations (PDF) |
| 316 | Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer | 2.8 | 11 | Citations (PDF) |
| 317 | Deregulation of cofactor of BRCA1 expression in breast cancer cells | 1.8 | 35 | Citations (PDF) |
| 318 | Claudin‐16 reduces the aggressive behavior of human breast cancer cells | 1.8 | 37 | Citations (PDF) |
| 319 | Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1 | 1.8 | 37 | Citations (PDF) |
| 320 | Genetic upregulation of matriptase‐2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation | 2.5 | 30 | Citations (PDF) |
| 321 | Lymphangiogenesis and lymph node metastasis in breast cancer | 19.9 | 35 | Citations (PDF) |
| 322 | Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome | 1.4 | 12 | Citations (PDF) |
| 323 | HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells | 0.8 | 20 | Citations (PDF) |
| 324 | Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells | 0.8 | 20 | Citations (PDF) |
| 325 | Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome | 19.9 | 98 | Citations (PDF) |
| 326 | WAVE1 is Associated With Invasiveness and Growth of Prostate Cancer Cells | 3.1 | 26 | Citations (PDF) |
| 327 | Contribution of BRCA1 germline mutation in patients with sporadic breast cancer | 0.0 | 7 | Citations (PDF) |
| 328 | Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis | 2.2 | 13 | Citations (PDF) |
| 329 | Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4 | 2.0 | 85 | Citations (PDF) |
| 330 | The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer | 0.0 | 59 | Citations (PDF) |
| 331 | Is N-Cadherin Expression Important in Ductal Carcinoma? | 0.4 | 4 | Citations (PDF) |
| 332 | Molecular cloning and promoter analysis of downregulated in adenoma (DRA) | 1.8 | 47 | Citations (PDF) |
| 333 | Angiopoietins lack of prognostic significance in ductal mammary carcinoma | 0.0 | 7 | Citations (PDF) |
| 334 | The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells | 3.8 | 12 | Citations (PDF) |
| 335 | Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis | 2.2 | 50 | Citations (PDF) |
| 336 | Bone metastasis in prostate cancer: Molecular and cellular mechanisms (Review) | 3.8 | 23 | Citations (PDF) |
| 337 | Endogenous Bone Morphogenetic Protein-7 Controls the Motility of Prostate Cancer Cells Through Regulation of Bone Morphogenetic Protein Antagonists | 3.1 | 49 | Citations (PDF) |
| 338 | Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro | 3.8 | 7 | Citations (PDF) |
| 339 | Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid | 1.8 | 30 | Citations (PDF) |
| 340 | Cyclooxygenase‐2 mRNA expression correlates with aromatase expression in human breast cancer | 1.2 | 17 | Citations (PDF) |
| 341 | Tumour-associated angiogenesis in human colorectal cancer | 1.7 | 78 | Citations (PDF) |
| 342 | Hepatocyte growth factor regulation: An integral part of why wounds become chronic | 2.0 | 34 | Citations (PDF) |
| 343 | The role of vascular endothelial growth inhibitor in wound healing | 2.2 | 27 | Citations (PDF) |
| 344 | Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer | 1.7 | 84 | Citations (PDF) |
| 345 | The Role of Growth Differentiation Factor-9 (GDF-9) and Its Analog, GDF-9b/BMP-15, in Human Breast Cancer | 1.7 | 34 | Citations (PDF) |
| 346 | The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome | 1.8 | 46 | Citations (PDF) |
| 347 | N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer | 1.9 | 41 | Citations (PDF) |
| 348 | Hepatocyte Growth Factor and the Hepatocyte Growth Factor Receptor Signalling Complex as Targets in Cancer Therapies | 2.0 | 5 | Citations (PDF) |
| 349 | Level of Expression of Parathyroid Hormone Related Protein and its Receptor in Human Breast Cancer and its Correlation with the Clinical Outcome | 0.0 | 5 | Citations (PDF) |
| 350 | Novel Potential Anticancer Naphthyl Phosphoramidates of BVdU: Separation of Diastereoisomers and Assignment of the Absolute Configuration of the Phosphorus Center | 4.0 | 38 | Citations (PDF) |
| 351 | Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS | 1.8 | 88 | Citations (PDF) |
| 352 | Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer | 1.5 | 53 | Citations (PDF) |
| 353 | Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer | 1.5 | 93 | Citations (PDF) |
| 354 | Expression of breast cancer specific gene-1 (BCSG-1/γ-synuclein) is associated with tumour grade but not with clinical outcome of patients with breast cancer | 2.2 | 3 | Citations (PDF) |
| 355 | Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome | 3.8 | 21 | Citations (PDF) |
| 356 | Com-1/p8 acts as a putative tumour suppressor in prostate cancer | 3.8 | 15 | Citations (PDF) |
| 357 | The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells | 2.2 | 3 | Citations (PDF) |
| 358 | Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells | 3.8 | 10 | Citations (PDF) |
| 359 | Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance | 3.6 | 23 | Citations (PDF) |
| 360 | The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing | 2.0 | 97 | Citations (PDF) |
| 361 | Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer | 1.7 | 72 | Citations (PDF) |
| 362 | The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer | 1.8 | 38 | Citations (PDF) |
| 363 | The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue | 1.8 | 23 | Citations (PDF) |
| 364 | Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients | 5.8 | 56 | Citations (PDF) |
| 365 | Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer | 2.1 | 57 | Citations (PDF) |
| 366 | Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation | 1.8 | 25 | Citations (PDF) |
| 367 | Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation | 2.8 | 256 | Citations (PDF) |
| 368 | Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells | 2.8 | 85 | Citations (PDF) |
| 369 | Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer | 0.8 | 57 | Citations (PDF) |
| 370 | Pigment Epithelium-derived Factor Inhibits Angiogenesis via Regulated Intracellular Proteolysis of Vascular Endothelial Growth Factor Receptor 1 | 1.3 | 208 | Citations (PDF) |
| 371 | Rapid Molecular and Morphological Responses of Prostate Cell Lines to Cell–Cell Contact | 3.3 | 5 | Citations (PDF) |
| 372 | Title is missing! | 0.0 | 56 | Citations (PDF) |
| 373 | Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin | 2.1 | 54 | Citations (PDF) |
| 374 | Hepatocyte growth factor, its receptor, and their potential value in cancer therapies | 3.5 | 243 | Citations (PDF) |
| 375 | Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer | 1.7 | 457 | Citations (PDF) |
| 376 | Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin | 2.6 | 25 | Citations (PDF) |
| 377 | The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer | 0.9 | 127 | Citations (PDF) |
| 378 | Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status | 2.8 | 20 | Citations (PDF) |
| 379 | Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis | 0.4 | 44 | Citations (PDF) |
| 380 | Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment | 0.4 | 67 | Citations (PDF) |
| 381 | E-cadherin and its associated protein catenins, cancer invasion and metastasis | 0.4 | 74 | Citations (PDF) |
| 382 | Inhibition of neutrophil respiratory burst and cytokine priming by γ-linolenic acid | 0.4 | 7 | Citations (PDF) |
| 383 | Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo | 0.4 | 46 | Citations (PDF) |
| 384 | The Coxsackie-adenovirus receptor has elevated expression in human breast cancer | 2.2 | 43 | Citations (PDF) |
| 385 | Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™ | 1.6 | 163 | Citations (PDF) |
| 386 | KiSS-1 Expression in Human Breast Cancer | 1.9 | 88 | Citations (PDF) |
| 387 | Evaluation of the Bioequivalence and Pharmacokinetics of Two Formulations of Rizatriptan after Single Oral Administration in Healthy Volunteers | 0.8 | 7 | Citations (PDF) |
| 388 | NAPHTHYL PHOSPHORAMIDATE DERIVATIVES OF BVdU AS POTENTIAL ANTICANCER AGENTS: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION | 0.7 | 30 | Citations (PDF) |
| 389 | Tight junctions and bladder cancer (Review) | 3.8 | 8 | Citations (PDF) |
| 390 | Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-β connection | 1.5 | 39 | Citations (PDF) |
| 391 | TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains | 1.5 | 33 | Citations (PDF) |
| 392 | Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: The role of promoter methylation of TSC genes | 2.8 | 100 | Citations (PDF) |
| 393 | Placenta growth factor is over-expressed and has prognostic value in human breast cancer | 2.8 | 127 | Citations (PDF) |
| 394 | Molecular and cellular mechanisms of lymphangiogenesis | 0.9 | 62 | Citations (PDF) |
| 395 | Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes | 1.5 | 126 | Citations (PDF) |
| 396 | γ-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells | 1.5 | 25 | Citations (PDF) |
| 397 | Title is missing! | 1.4 | 56 | Citations (PDF) |
| 398 | Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer | 3.4 | 159 | Citations (PDF) |
| 399 | Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro | 2.2 | 2 | Citations (PDF) |
| 400 | Level of the Expression of VEGF-A, B, C, D and their Receptors (FLT-1, KDR and FLT-4) and its Correlation with Prognosis in Patients with Colorectal Cancer | 0.0 | 3 | Citations (PDF) |
| 401 | Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes | 3.6 | 10 | Citations (PDF) |
| 402 | The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer | 3.8 | 196 | Citations (PDF) |
| 403 | Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer | 1.9 | 103 | Citations (PDF) |
| 404 | Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells | 1.6 | 36 | Citations (PDF) |
| 405 | Hepatocyte growth factor disrupts tight junctions in human breast cancer cells | 2.0 | 46 | Citations (PDF) |
| 406 | Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator | 3.4 | 107 | Citations (PDF) |
| 407 | Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer | 2.8 | 82 | Citations (PDF) |
| 408 | Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer | 2.8 | 144 | Citations (PDF) |
| 409 | Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression | 0.9 | 31 | Citations (PDF) |
| 410 | The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancer | 2.2 | 22 | Citations (PDF) |
| 411 | The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo | 2.8 | 48 | Citations (PDF) |
| 412 | Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes | 2.8 | 162 | Citations (PDF) |
| 413 | Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells | 2.5 | 93 | Citations (PDF) |
| 414 | Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway | 0.4 | 29 | Citations (PDF) |
| 415 | The role of the CD44/ezrin complex in cancer metastasis | 3.5 | 212 | Citations (PDF) |
| 416 | Effect of human fibroblast-derived dermis on expansion of tissue from venous leg ulcers | 2.0 | 3 | Citations (PDF) |
| 417 | Androgen and PPARγ ligand ciglitizone, regulates cell proliferation, cyclin D levels and cyclin dependent kinase inhibitors p27Kip1 and p57Kip2 in prostate cancer cells | 0.1 | 0 | Citations (PDF) |
| 418 | A hammerhead ribozyme transgene to the human HGF/SF receptor c-Met reduces in vitro invasion and migration in prostate cancer cells | 0.1 | 0 | Citations (PDF) |
| 419 | Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer | 1.5 | 97 | Citations (PDF) |
| 420 | Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist | 2.2 | 75 | Citations (PDF) |
| 421 | Quantitative analysis of lymphangiogenic markers in human colorectal cancer | 3.6 | 31 | Citations (PDF) |
| 422 | Expression of human delta-6-desaturase is associated with aggressiveness of human breast cancer | 3.8 | 9 | Citations (PDF) |
| 423 | Expression of transglutaminases in human breast cancer and their possible clinical significance | 2.2 | 10 | Citations (PDF) |
| 424 | Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction | 3.6 | 13 | Citations (PDF) |
| 425 | From PCR to RCA: a surgical trainee's guide to the techniques of genetic amplification | 0.9 | 1 | Citations (PDF) |
| 426 | Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells | 2.5 | 70 | Citations (PDF) |
| 427 | Endosperm-specific expression of green fluorescent protein driven by the hordein promoter is stably inherited in transgenic barley (Hordeum vulgare
) plants | 2.2 | 88 | Citations (PDF) |
| 428 | Cell adhesion molecules and adhesion abnormalities in prostate cancer | 3.5 | 55 | Citations (PDF) |
| 429 | Molecular detection of micro-metastasis in breast cancer | 3.5 | 30 | Citations (PDF) |
| 430 | The HGF/SF-Induced Phosphorylation of Paxillin, Matrix Adhesion, and Invasion of Prostate Cancer Cells Were Suppressed by NK4, an HGF/SF Variant | 1.5 | 50 | Citations (PDF) |
| 431 | Lymphangiogenesis Quantification Using Quantitative PCR and Breast Cancer as a Model | 1.5 | 35 | Citations (PDF) |
| 432 | Matrix‐bound fibroblasts regulate angiogenesis by modulation of VE‐cadherin | 2.2 | 27 | Citations (PDF) |
| 433 | Phenotypic variation in the production of bioactive hepatocyte growth factor/scatter factor by oral mucosal and skin fibroblasts | 2.0 | 33 | Citations (PDF) |
| 434 | Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells | 3.6 | 14 | Citations (PDF) |
| 435 | HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells | 3.8 | 29 | Citations (PDF) |
| 436 | The interaction between β-catenin, GSK3β and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer | 3.6 | 14 | Citations (PDF) |
| 437 | Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells | 2.8 | 63 | Citations (PDF) |
| 438 | E-cadherin complex and its abnormalities in human breast cancer | 1.0 | 43 | Citations (PDF) |
| 439 | Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4 | 1.8 | 37 | Citations (PDF) |
| 440 | The pathology of essential fatty acid deficiency: is it cell adhesion mediated? | 0.5 | 17 | Citations (PDF) |
| 441 | Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells | 1.5 | 68 | Citations (PDF) |
| 442 | Paternal Origin of FGFR2 Mutations in Sporadic Cases of Crouzon Syndrome and Pfeiffer Syndrome | 4.0 | 200 | Citations (PDF) |
| 443 | CELL-CELL ADHESION MOLECULES AND SIGNALING INTERMEDIATES AND THEIR ROLE IN THE INVASIVE POTENTIAL OF PROSTATE CANCER CELLS | 3.1 | 0 | Citations (PDF) |
| 444 | Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells. | 3.8 | 14 | Citations (PDF) |
| 445 | Overexpression of thioredoxin h leads to enhanced activity of starch debranching enzyme (pullulanase) in barley grain | 5.2 | 128 | Citations (PDF) |
| 446 | Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer | 3.5 | 243 | Citations (PDF) |
| 447 | Higher DNA Adduct Levels in Urinary Bladder and Prostate of Slow Acetylator Inbred Rats Administered 3,2′-Dimethyl-4-Aminobiphenyl | 2.2 | 13 | Citations (PDF) |
| 448 | Title is missing! | 5.8 | 51 | Citations (PDF) |
| 449 | Interactive image processing system for assessment of cell movement | 1.8 | 10 | Citations (PDF) |
| 450 | Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells 1999, 181, 319-329 | | 93 | Citations (PDF) |
| 451 | Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid | 1.5 | 21 | Citations (PDF) |
| 452 | De Novo Alu-Element Insertions in FGFR2 Identify a Distinct Pathological Basis for Apert Syndrome | 4.0 | 239 | Citations (PDF) |
| 453 | A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 Gene | 4.0 | 159 | Citations (PDF) |
| 454 | The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer | 2.8 | 35 | Citations (PDF) |
| 455 | High-frequency transformation of oat via microprojectile bombardment of seed-derived highly regenerative cultures | 3.0 | 53 | Citations (PDF) |
| 456 | Inhibition of the Expression of VE-Cadherin/Catenin Complex by Gamma Linolenic Acid in Human Vascular Endothelial Cells, and Its Impact on Angiogenesis | 1.5 | 34 | Citations (PDF) |
| 457 | Association of the HGF/SF Receptor, c-met, with the Cell-Surface Adhesion Molecule, E-Cadherin, and Catenins in Human Tumor Cells | 1.5 | 114 | Citations (PDF) |
| 458 | A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response | 6.6 | 718 | Citations (PDF) |
| 459 | Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/β-catenin | 1.7 | 145 | Citations (PDF) |
| 460 | The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells | 4.1 | 41 | Citations (PDF) |
| 461 | Cell adhesion molecules in the formation of liver metastasis | 2.0 | 14 | Citations (PDF) |
| 462 | Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications | 3.5 | 116 | Citations (PDF) |
| 463 | Transformation of recalcitrant barley cultivars through improvement of regenerability and decreased albinism | 3.0 | 144 | Citations (PDF) |
| 464 | Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro | 1.5 | 24 | Citations (PDF) |
| 465 | Regulation of Tight Junction Permeability and Occludin Expression by Polyunsaturated Fatty Acids | 1.5 | 116 | Citations (PDF) |
| 466 | gamma-Linolenic acid blocks cell cycle progression by regulating phosphorylation of p27kip1 and p57kip2 and their interactions with other cycle regulators in cancer cells. | 3.6 | 5 | Citations (PDF) |
| 467 | Association of PTPmu with catenins in cancer cells: a possible role for E-cadherin. | 3.6 | 10 | Citations (PDF) |
| 468 | Regulation of cell adhesion, a central mechanism in the anticancer action of essential fatty acids (review). | 3.8 | 4 | Citations (PDF) |
| 469 | Gap junctional communication and the tyrosine phosphorylation of connexin 43 in interaction between breast cancer and endothelial cells. | 3.8 | 11 | Citations (PDF) |
| 470 | Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea | 1.8 | 81 | Citations (PDF) |
| 471 | E-cadherin and associated molecules in the invasion and progression of prostate cancer. | 2.2 | 15 | Citations (PDF) |
| 472 | Expression of the HGF/SF Receptor, c-met, and Its Ligand in Human Colorectal Cancers | 1.1 | 50 | Citations (PDF) |
| 473 | Regulation of Endothelial CD44 Expression and Endothelium–Tumour Cell Interactions by Hepatocyte Growth Factor/Scatter Factor | 1.5 | 40 | Citations (PDF) |
| 474 | Identification of a Novel Allele at the HumanNAT1Acetyltransferase Locus | 1.5 | 55 | Citations (PDF) |
| 475 | Gamma Linolenic Acid Regulates Expression of Maspin and the Motility of Cancer Cells | 1.5 | 48 | Citations (PDF) |
| 476 | Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells | 1.5 | 27 | Citations (PDF) |
| 477 | Quantification of tumour cell—endothelial cell attachment by 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine (DiI) | 6.5 | 15 | Citations (PDF) |
| 478 | Rodent models of the human acetylation polymorphism: Comparisons of recombinant acetyltransferases | 1.2 | 63 | Citations (PDF) |
| 479 | Higher Frequency of Aberrant Crypt Foci in Rapid Than Slow Acetylator Inbred Rats Administered the Colon Carcinogen 3,2′-Dimethyl-4-aminobiphenyl | 2.2 | 21 | Citations (PDF) |
| 480 | Title is missing! | 1.9 | 22 | Citations (PDF) |
| 481 | Prenatal ultrasonographic and molecular diagnosis of apert syndrome 1997, 17, 1081-1084 | | 42 | Citations (PDF) |
| 482 | 2-aminofluorene-DNA adduct levels in tumor-target and nontargetorgans of rapid and slow acetylator syrian hamsters congenic at the NAT2 locus | 2.2 | 14 | Citations (PDF) |
| 483 | 3,2′-Dimethyl-4-aminobiphenyl-DNA Adduct Formation in Tumor Target and Nontarget Organs of Rapid and Slow Acetylator Syrian Hamsters Congenic at theNAT2Locus | 2.2 | 11 | Citations (PDF) |
| 484 | Plasma cytokine levels and monocyte activation in patients with obstructive jaundice | 1.8 | 41 | Citations (PDF) |
| 485 | Inhibition of motility and invasion of human lung cancer cells by invasion inhibiting factor 2 | 1.0 | 8 | Citations (PDF) |
| 486 | 2-Aminofluorene–DNA Adduct Levels in Tumor-Target and Nontarget Organs of Rapid and Slow Acetylator Syrian Hamsters Congenic at theLocus | 2.2 | 7 | Citations (PDF) |
| 487 | Inhibition of cancer cell motility and invasion by interleukin-12 | 1.9 | 37 | Citations (PDF) |
| 488 | Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid | 4.1 | 123 | Citations (PDF) |
| 489 | Induction of Tyrosine Phosphorylation and Translocation of Ezrin by Hepatocyte Growth Factor/Scatter Factor (HGF/SF) | 1.5 | 57 | Citations (PDF) |
| 490 | Inhibition of HGF/SF-Induced Membrane Ruffling and Cell Motility by Transient Elevation of Cytosolic Free Ca2+ | 2.1 | 16 | Citations (PDF) |
| 491 | Monocyte-conditioned media possess a novel factor which increases motility of cancer cells | 2.8 | 22 | Citations (PDF) |
| 492 | Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor | 1.9 | 73 | Citations (PDF) |
| 493 | U937 cells stimulated with opsonised zymozan particles provide a convenient laboratory source of tumour necrosis factor α | 1.0 | 8 | Citations (PDF) |
| 494 | Sensitivity of the Wound Edge Gene Signature “WD14” in Responding to Clinical Change: A Longitudinal Cohort Study | 1.0 | 1 | Citations (PDF) |
| 495 | Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer | 1.5 | 4 | Citations (PDF) |
| 496 | Tight junctional protein family, Claudins in cancer and cancer metastasis | 1.7 | 22 | Citations (PDF) |
| 497 | Predictive potential of hepatocyte growth factor and bone morphogenetic proteins in lymphatic metastasis of breast cancer | 1.4 | 1 | Citations (PDF) |
| 498 | Abstract PS4-03-30: Desmoplakin, DSP, is a potential tumour suppressive protein in human breast cancer | 4.5 | 0 | Citations (PDF) |
| 499 | Abstract PS3-11-01: Steroidogenic acute regulatory protein related lipid transfer domain containing-3 n-terminal like(STARD3NL) expression in clinical breast cancer and its connection with metastatic lymph node 64 (MLN64) in breast cancer | 4.5 | 0 | Citations (PDF) |
| 500 | Abstract PS2-12-28: Marveld1 expression in breast cancer and the impact on the aggressive nature of breast cancer cells | 4.5 | 0 | Citations (PDF) |
| 501 | SRS126 - MLN64 and StarD3NL highly correlated with the autophagy marker SQSTM1 and BECN1 in breast cancer, and indicate prognostic and therapeutic potential | 0.4 | 0 | Citations (PDF) |
| 502 | SRS123 - Clinical relevance of MarvelD2 as a prognostic biomarker in clinical breast cancer | 0.4 | 0 | Citations (PDF) |
| 503 | SRS85 Patey Prize Entrant - hENT1 inhibition as a strategy to overcome fluoropyrimidine resistance in colorectal cancer | 0.4 | 0 | Citations (PDF) |
| 504 | SRS387 - MLN64/StarD3 and StarD3NL in pancreatic cancer | 0.4 | 0 | Citations (PDF) |
| 505 | SRS359 - A novel association between disialoganglioside (GD2), GD2 synthesising enzymes and the Angiomotin family in breast cancer | 0.4 | 0 | Citations (PDF) |
| 506 | SRS133 - Nucleolin (NCL) in clinical breast cancer, the prognostic and therapeutic implications | 0.4 | 0 | Citations (PDF) |
| 507 | SRS127 - Afadin (AFDN) and the nectin protein complex in the development of metastasis of breast cancers | 0.4 | 0 | Citations (PDF) |
| 508 | Exploring nonviral nanocarriers as RNA delivery platforms for breast cancer treatment | 8.6 | 0 | Citations (PDF) |
| 509 | Elevated Protein Tyrosine Phosphatase Kappa Expression Is Associated With Disease Progression and Poor Prognosis of Pancreatic Cancer | 0.5 | 0 | Citations (PDF) |
| 510 | SLC27, solute carrier 27 family, a long-chain fatty acid membrane transporters, in human cancers | 2.8 | 0 | Citations (PDF) |
